For instance, a 2016 study by Ceccarelli et al. [77] utilized integrative multi-omics analysis to identify MGMT promoter methylation and IDH mutation subtypes in glioblastoma, which correlated with therapy response and survival outcomes. Here, MGMT is linked to glioblastoma.